TITLE

Quadrivalent HPV vaccine prevented cervical neoplasia caused by HPV-16 and HPV-18: COMMENTARY

AUTHOR(S)
Harper, Diane M.
PUB. DATE
September 2007
SOURCE
ACP Journal Club;Sept/Oct2007, Vol. 147 Issue 2, p49
SOURCE TYPE
Academic Journal
DOC. TYPE
Editorial
ABSTRACT
The article offers the author's comments on the effectiveness of quadrivalent human papillomavirus (HPV) vaccine in reducing the incidence of cervical cancer among all women. It is stated that although the vaccine has some limitations, to maintain public health support of HPV vaccinations, cervical disease reduction must occur as soon as possible. It is suggested that to accelerate this disease reduction, public health emphasis must be on vaccinating all women regardless of past HPV exposure.
ACCESSION #
27029984

 

Related Articles

  • Quadrivalent HPV vaccine prevented cervical neoplasia caused by HPV-16 and HPV-18.  // ACP Journal Club;Sept/Oct2007, Vol. 147 Issue 2, p49 

    The article discusses the effectiveness of quadrivalent vaccines against human papillomavirus (HPV) in healthy young women. It is stated that a quadrivalent vaccine against HPV types 6, 11, 16, and 18 was effective in preventing cervical neoplasia caused by HPV-16 or HPV-18 in healthy young...

  • Awareness, knowledge and attitudes related to HPV infection and vaccine among non-obstetrician-gynecologist healthcare providers. Naki, M. Murat; Çelik, Hasniye; Api, Oluş; Toprak, Sadık; Özerden, Erdem; Ünal, Orhan // Journal of the Turkish-German Gynecological Association;Mar2010, Vol. 11 Issue 1, p16 

    Objective: This study was designed to evaluate the awareness, knowledge and attitudes of healthcare providers related to HPV infection and vaccine. Material and Methods: A total of 311 healthcare providers working in specialties other than obstetrics and gynecology at the Dr. Lutfi Kırdar...

  • HPV jab is beneficial even after Ca treatment.  // Pulse;4/4/2012, Vol. 72 Issue 12, p9 

    The article focuses on the benefits of human papilloma virus (HPV) vaccination among women even after cervical cancer treatment, according to a research led by doctor Elmar Joura.

  • Share the Word during National Immunization Month: HPV Vaccine Saves Lives. Culwell, Kelly // La Prensa San Diego;8/8/2014, Vol. 38 Issue 32, p4 

    The article offers the author's view on the importance of undergoing routine vaccination of human papilloma virus (HPV) vaccine to prevent HPV and cervical cancer.

  • Association of Posttherapy Positron Emission Tomography With Tumor Response and Survival in Cervical Carcinoma. Schwarz, Julie K.; Siegel, Barry A.; Dehdashti, Farrokh; Grigsby, Perry W. // JAMA: Journal of the American Medical Association;11/21/2007, Vol. 298 Issue 19, p2289 

    This article reports on the findings of a study that examine the association of posttherapy positron emission tomography to tumor response and survival rates in women with cervical cancer. The development of the human papilloma virus (HPV) vaccine to prevent some cases of cervical cancer does...

  • Human Papillomavirus Vaccines. Chebib, Ivan; Duggan, Máire A. // Canadian Journal of Pathology;2010, Vol. 2 Issue 4, p24 

    Persistent infection with human papillomavirus (HPV) is the leading cause of cervical cancer and its precursor lesions, and the widespread use of cervical cytology screening has been a major factor in the control of this tumour in Canada. Primary prevention of cervical cancer through...

  • Aceptabilidad y conocimientos sobre la vacunación contra el virus del papiloma humano (VPH) en médicos ginecólogos de la Argentina. Mazzadi, Alejandro; Paolino, Melisa; Arrossi, Silvina // Salud Pública de México;sep/oct2012, Vol. 54 Issue 5, p515 

    Objective. To evaluate HPV vaccine acceptability and prescription; knowledge about HPV vaccine; and knowledge about HPV infection and cervical cancer among Argentinean gynecologists. Materials and methods. Between November 2009 and March 2010 we carried out an internet survey of 686...

  • What If Preventing Cancer Is as Easy as Being Vaccinated? Biedrzycki, Barbara A. // ONS News;Aug2006, Vol. 21 Issue 8, p9 

    The article reports on the development of a human papillomavirus (HPV) vaccine intended for the prevention of cervical cancer among men and women worldwide. HPV has been sought to be the most common sexually transmitted disease with 20 million men and women have been infected. With the approval...

  • Central European Vaccination Advisory Group (CEVAG) guidance statement on recommendations for the introduction of HPV vaccines. Prymula, Roman; Anca, Ioana; André, Francis; Bakir, Mustafa; Czajka, Hanna; Lutsar, Irja; Mészner, Zsófia; Salman, Nuran; Šimurka, Pavol; Usonis, Vytautas // European Journal of Pediatrics;Sep2009, Vol. 168 Issue 9, p1031 

    Vaccines against human papillomavirus (HPV), the primary causative agent in cervical cancer, are licensed. This paper contains the Central European Vaccination Advisory Group (CEVAG) guidance statement on the introduction of HPV vaccines in central Europe. Eight countries currently have medical...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics